Literature DB >> 24372709

Inflammatory markers and pulmonary granuloma infiltration in sarcoidosis.

Marjeta Terčelj1, Barbara Salobir1, Mirjana Zupancic2, Branka Wraber3, Ragnar Rylander4.   

Abstract

BACKGROUND AND
OBJECTIVE: Previous studies have demonstrated increases of inflammatory mediators in sarcoidosis while epidemiological studies have also demonstrated an association with increased fungi exposure. This study measured the level of β-glucan in the lungs and of inflammatory mediators in serum, and correlated both with the extent of pulmonary granuloma infiltration.
METHODS: This is a cross-sectional study of 98 patients with sarcoidosis and 26 controls. β-glucan, a cell wall constituent of fungi, was measured in bronchoalveolar lavage. Inflammatory mediator levels were determined in serum. The extent of granuloma infiltration was estimated on the chest X-ray. Exposure to fungi at home was determined by taking air samples in bedrooms and analysing for the presence of β-N-acetylhexosaminidase.
RESULTS: Significantly, higher levels of β-glucan were found in broncho-alveolar lavage in subjects with sarcoidosis as compared with controls. There were significant positive relationships between the extent of granuloma infiltration and the levels of the different inflammatory mediators, except for interleukin-10. Domestic fungal exposure was higher among subjects with sarcoidosis.
CONCLUSIONS: This is the first time that a specific agent, previously suspected to be related to the risk of sarcoidosis, has been detected in the lung of subjects with sarcoidosis and related to the levels of inflammatory mediators and the degree of home exposure to fungi. The results suggest that exposure to fungi should be explored when investigating patients with sarcoidosis.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Keywords:  fungi; inflammation; sarcoidosis; β-N-acetylhexosaminidase; β-glucan

Mesh:

Substances:

Year:  2013        PMID: 24372709     DOI: 10.1111/resp.12199

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  11 in total

1.  β-glucan in the lymph nodes in sarcoidosis and in Kveim-Siltzbach test reagent.

Authors:  Marjeta Terčelj; Barbara Salobir; Ragnar Rylander
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.

Authors:  George P Christophi; Tiffany Caza; Christopher Curtiss; Divya Gumber; Paul T Massa; Steve K Landas
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

3.  Fungal exposure and low levels of IL-10 in patients with sarcoidosis.

Authors:  Marjeta Terčelj; Sanja Stopinšek; Alojz Ihan; Barbara Salobir; Saša Simčič; Ragnar Rylander
Journal:  Pulm Med       Date:  2014-08-07

Review 4.  Interleukin-12 family cytokines and sarcoidosis.

Authors:  Sabine Ringkowski; Paul S Thomas; Cristan Herbert
Journal:  Front Pharmacol       Date:  2014-10-27       Impact factor: 5.810

5.  Sarcoidosis treatment with antifungal medication: a follow-up.

Authors:  Marjeta Terčelj; Barbara Salobir; Mirjana Zupancic; Ragnar Rylander
Journal:  Pulm Med       Date:  2014-12-04

6.  Pulmonary and extra-pulmonary manifestations of sarcoidosis.

Authors:  Sasan Tavana; Masoumeh Alizadeh; Seyed Amir Mohajerani; Seyed Mohammadreza Hashemian
Journal:  Niger Med J       Date:  2015 Jul-Aug

7.  Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure: S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM).

Authors:  Gerhard A Wiesmüller; Birger Heinzow; Ute Aurbach; Karl-Christian Bergmann; Albrecht Bufe; Walter Buzina; Oliver A Cornely; Steffen Engelhart; Guido Fischer; Thomas Gabrio; Werner Heinz; Caroline E W Herr; Jörg Kleine-Tebbe; Ludger Klimek; Martin Köberle; Herbert Lichtnecker; Thomas Lob-Corzilius; Rolf Merget; Norbert Mülleneisen; Dennis Nowak; Uta Rabe; Monika Raulf; Hans Peter Seidl; Jens-Oliver Steiß; Regine Szewszyk; Peter Thomas; Kerttu Valtanen; Julia Hurraß
Journal:  Allergo J Int       Date:  2017-02-28

8.  Human Bronchial Epithelial Cells Induce CD141/CD123/DC-SIGN/FLT3 Monocytes That Promote Allogeneic Th17 Differentiation.

Authors:  Amiq Gazdhar; Fabian Blank; Valerie Cesson; Alban Lovis; John David Aubert; Romain Lazor; Francois Spertini; Anne Wilson; Katrin Hostettler; Laurent P Nicod; Carolina Obregon
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

9.  An Evolutionary-Based Framework for Analyzing Mold and Dampness-Associated Symptoms in DMHS.

Authors:  Alvaro Daschner
Journal:  Front Immunol       Date:  2017-01-09       Impact factor: 7.561

10.  Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people.

Authors:  Seyed Ali Alavi Foumani; Siamak Geranmayeh; Azita Tangestani Nejad; Aydin Pour Kazemi; Ehsan Kazem Nejad Leili; Alireza Jafari; Mehrzad Amooei Khanabbasi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.